← Evidence map

ArticleInternational journal of urology : official journal of the Japanese Urological Association2022

Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).

Satoru Taguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35996761